Agion® Inactivates the SARS-CoV-2 Virus in Just 5 Minutes, Even After 20 Washes

With the coronavirus outbreak continuing, so has Sciessent’s dedication to doing our part to stop the spread. We worked with a consortium of companies to add Agion® to hundreds of millions of masks to help in the global fight against the coronavirus.

Today we have very exciting news to announce. Agion® has been tested by Microbac Laboratories, a leading contract laboratory for virus testing and among the first in the US to establish testing with SARS-CoV-2, and the results are in: Agion® inactivates 99.8% of SARS-CoV-2 in just 5 minutes even after 20 washes.

Now, we know some other suppliers have suggested that “washability remains a challenge”, but that really depends on what technology you use. Agion® is built for unprecedented durability, so that is not a problem for us.

We had another post about validating ISO 18184 test results that you see from antimicrobial suppliers. In that post we talked about examining the data on the control fabric. Any ISO 18184 test results that show a control fabric with antiviral efficacy of more than 90% is considered invalid data.

It’s important to note that in our test, the virus maintained high activity on the control fabric, confirming the validity of our data per the ISO 18184 standard.

While this is exciting news for Sciessent, and more importantly our partners, it’s important to remember that antiviral claims are not permitted in the USA without proper clearance by the governing regulatory bodies.
Want to learn more about Agion Antimcrobial, and how it can add value to your products? Reach out, we’d love to hear from you.

Let’s Talk

The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration in the US; those medical device claims are based on safety and efficacy testing and are limited to those approved by FDA.